发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 225 |
| CHINA MAINLAND | 162 |
| Japan | 152 |
| England | 44 |
| France | 38 |
| Italy | 31 |
| Netherlands | 31 |
| GERMANY (FED REP GER) | 30 |
| Switzerland | 27 |
| Australia | 18 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| NATIONAL CANCER CENTER - JAPAN | 24 |
| ROCHE HOLDING | 24 |
| UNIVERSITY OF TEXAS SYSTEM | 21 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 20 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 18 |
| PFIZER | 17 |
| HARVARD UNIVERSITY | 16 |
| NETHERLANDS CANCER INSTITUTE | 15 |
| OSAKA UNIVERSITY | 14 |
| UNICANCER | 14 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Advances in ovarian cancer therapy | 78 |
| Positioning of proteasome inhibitors in therapy of solid... | 24 |
| Retreatment with pembrolizumab in advanced non-small cel... | 22 |
| A panel of serum exosomal microRNAs as predictive marker... | 20 |
| A phase 1 dose-escalation study on the safety, tolerabil... | 19 |
| Autophagy modulation: a prudent approach in cancer treat... | 18 |
| Alternative dosing regimens for atezolizumab: an example... | 16 |
| A phase II study of modified FOLFIRINOX for chemotherapy... | 15 |
| Cancer immunotherapy: the art of targeting the tumor imm... | 15 |
| The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivi... | 15 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCER CHEMOTH PHARM | 227 |
| CANCERS | 197 |
| INT J MOL SCI | 187 |
| SCI REP-UK | 126 |
| FRONT ONCOL | 104 |
| MOLECULES | 81 |
| ONCOL LETT | 78 |
| CANCER MANAG RES | 76 |
| BMC CANCER | 75 |
| ANTICANCER RES | 73 |